A chronic recurrent disease course of dermatomyositis is associated with autoantibodies against transcriptional intermediary factor 1-γ

Br J Dermatol. 2017 Aug;177(2):590-593. doi: 10.1111/bjd.15468. Epub 2017 Jul 5.

Authors

S Meisterfeld¹, N Röber², K Conrad², S Beissert¹, M Aringer³, C Günther¹

Affiliations

¹ Department of Dermatology, Department of Medicine III, University Hospital, Dresden, Germany.
² Institute of Immunology Faculty of Medicine Carl Gustav Carus, Technical University Dresden, Dresden, Germany.
³ Rheumatology, Department of Medicine III, University Hospital, Dresden, Germany.

PMID: 28314058
DOI: 10.1111/bjd.15468

No abstract available

Publication types

Letter

MeSH terms

Adolescent
Adult
Aged
Autoantibodies / metabolism*
Child
Chronic Disease
Dermatomyositis / immunology*
Dermatomyositis / therapy
Disease Progression
Female
Humans
Male
Middle Aged
Nuclear Proteins / immunology*
Recurrence
Transcription Factors / immunology*
Treatment Outcome
Young Adult

Substances

Autoantibodies
Nuclear Proteins
Transcription Factors
transcriptional intermediary factor 1